Home › Funds › Maverick Capital › RCKT
Maverick Capital position in RCKT
ROCKET PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)3.92M sh
Reported value held$13.42M
Portfolio Weight0.12%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.66M | $49.62M | New |
| Q4 2021 | 1.89M | $41.37M | Add |
| Q1 2022 | 2.13M | $33.83M | Add |
| Q2 2022 | 2.53M | $34.84M | Add |
| Q3 2022 | 2.53M | $40.42M | Hold |
| Q4 2022 | 3.40M | $66.46M | Add |
| Q1 2023 | 4.41M | $75.50M | Add |
| Q2 2023 | 4.38M | $87.03M | Reduce |
| Q3 2023 | 5.63M | $115.36M | Add |
| Q4 2023 | 4.03M | $120.90M | Reduce |
| Q1 2024 | 3.89M | $104.75M | Reduce |
| Q2 2024 | 3.93M | $84.58M | Add |
| Q3 2024 | 4.12M | $76.07M | Add |
| Q4 2024 | 5.20M | $65.35M | Add |
| Q1 2025 | 5.20M | $34.68M | Hold |
| Q2 2025 | 8.36M | $20.49M | Add |
| Q3 2025 | 8.47M | $27.61M | Add |
| Q4 2025 | 2.51M | $8.82M | Reduce |
| Q1 2026 | 3.57M | $12.77M | Add |
| Q2 2026 | 3.92M | $13.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RCKT
- BlackRock Inc 9.92M sh · $33.94M · Q2 2026
- Vanguard Group 8.54M sh · $29.99M · Q4 2025
- Citigroup Inc 4.87M sh · $16.64M · Q2 2026
- Marshall Wace 4.03M sh · $13.78M · Q2 2026
- Millennium Management 4.00M sh · $13.68M · Q2 2026
- AQR Capital Management 3.39M sh · $11.58M · Q2 2026
- Goldman Sachs Group 2.97M sh · $10.17M · Q2 2026
- Geode Capital Management 2.37M sh · $8.11M · Q2 2026
- JPMorgan Chase & Co 1.99M sh · $6.70M · Q2 2026
- Morgan Stanley 1.06M sh · $3.63M · Q2 2026
- D. E. Shaw & Co 950.55K sh · $3.25M · Q2 2026